- Primary research
- Open Access
Vitamin K3 and vitamin C alone or in combination induced apoptosis in leukemia cells by a similar oxidative stress signalling mechanism
Cancer Cell Internationalvolume 11, Article number: 19 (2011)
Secondary therapy-related acute lymphoblastic leukemia might emerge following chemotherapy and/or radiotherapy for primary malignancies. Therefore, other alternatives should be pursued to treat leukemia.
It is shown that vitamin K3- or vitamin C- induced apoptosis in leukemia cells by oxidative stress mechanism involving superoxide anion radical and hydrogen peroxide generation, activation of NF-κB, p53, c-Jun, protease caspase-3 activation and mitochondria depolarization leading to nuclei fragmentation. Cell death was more prominent when Jurkat and K562 cells are exposed to VC and VK3 in a ratio 1000:1 (10 mM: 10 μM) or 100:1 (300 μM: 3 μM), respectively.
We provide for the first time in vitro evidence supporting a causative role for oxidative stress in VK3- and VC-induced apoptosis in Jurkat and K562 cells in a domino-like mechanism. Altogether these data suggest that VK3 and VC should be useful in the treatment of leukemia.
Leukemia is a cancer of the bone marrow and blood. The cause of this hematological disorder is currently still unknown. Today, first-line therapy for the treatment of leukemia includes chemotherapy and radiotherapy. Unfortunately, secondary therapy-related acute lymphoblastic leukemia might emerge following chemotherapy and/or radiotherapy for primary malignancies . Therefore, other therapeutic alternatives based on the reactivation of the apoptotic program should be pursued to eliminate cancer cells . Accordingly, the use of vitamin K3 (VK3, also known as menadione ) and vitamin C (VC, also known as sodium ascorbate ) alone or in combination (VK3: VC ) is highly promising in cancer treatment. Yet, the precise pathway(s) by which VK3 and/or VC induce leukemia cell death are not well established. Moreover, given the complexity of death pathways within a cell, placing these pathways in the proper relationship to the drug trigger is challenging.
During the last three decades, vitamin K3 has been known to display anti-tumor action both in vivo and in vitro in human cancer cell lines . Several observations suggest that vitamin K3 might induce apoptosis -a type of cell death-  through different biochemical routes including severe depletion of glutathione and sulfhydryl-containing proteins and alteration of intracellular Ca2+ homeostasis , activation of c-Jun NH2-terminal kinase (JNK, ), activation of Fas/Fas ligand system independently of the pro-apoptotic p53 protein , activation of Fas-dependent and Fas-independent pathways  and NF-κB activation . Because most studies have looked at a given pathway in isolation using different cell types, the potential interaction between pathways have often not been addressed. Therefore, the complete mechanism(s) of cell death signalization induced by vitamin K3 in a single cell model remains unclear.
Vitamin C is a water-soluble vitamin effective as antioxidant compound under normal conditions . However, Chen and collaborators [13, 14] have shown that pharmacological concentrations of (5-15 mM) vitamin C was pro-oxidant, generating H2O2-dependent cytotoxicity toward a variety of cancer cells in vitro and in vivo without adversely affecting normal cells. Interestingly, it has been shown that (10 μM) VK3 in combination of (2 mM) VC kill leukemia cells (e.g., K562 cells) by oxidative stress independent of caspase-3, with a minor percentage of cell displaying mitochondrial depolarisation and DNA fragmentation without chromatin condensation consistent with a necrosis-like cell death . Yet, the mechanism by which vitamin C-induced apoptosis in Jurkat and K562 cells is not yet fully established.
Since it is known that the transcription factor NF-κB , p53 , c-Jun  and caspase-3  are involved in apoptosis signaling, we hypothesized that VK3 and VC might induce cell death in leukemia cells through activation of such factors by oxidative stress. To test this assumption, we sought to investigate the molecular mechanism by which VC, VK3 alone or in combination (ratio 100:1 ) induce cell death in Jurkat (clone E06-1) and K562 leukemia cell lines and lymphocyte cells in relation to the aforementioned pro-apoptotic transcription factors and caspase-3. Although, the role of vitamin C as therapeutic compound is still controversial , understanding the mechanism of vitamins alone or together may provide insight into more effective anti-cancer therapy.
Vitamin K3 (VK3) and vitamin C (VC) alone or in combination induce apoptosis in Jurkat and K562 cells through anion superoxide radical (O2.-)/H2O2 generation and mitochondrial damage
Figure 1A and 1B show that VK3 and VC provoked typical morphological features of apoptosis in a concentration-dependent fashion according to the conventional AO/EB staining technique . However, (early/late) apoptosis and necrosis (~20%-50%) morphology of cell death were observed at high VK3 (e.g., 35 μM for both cells) and VC (e.g., 20 mM for Jurkat and > 1 mM for K562) concentrations (insets). Remarkably, K562 cells were the most sensible to VC, whereas both cell lines were more sensible to VK3 than lymphocytes (e.g. Jurkat and K562 cells displayed ~40% & ~25% AO/EB positive nuclei whereas lymphocytes displayed about 3% AO/EB positive nuclei when exposed to 10 μM VK3). These results prompted us to fully examine the effect of VK3 and VC on Jurkat cell line.
Figure 1C shows that VK3 produced both anion superoxide radical (O2.-) and H2O2 in a concentration-dependent fashion up-to 20 μM, e.g. 94% and 43% percent of formazan (Figure 2A) and DCF positive (Figure 2B), respectively in Jurkat cells. Figure 1C also shows that increasing concentrations of VK3 induced mitochondrial depolarization, as reflected by DiOC6(3) non-fluorescent cells (Figure 2C) in a concentration-dependent fashion. Interestingly, apoptotic morphological alterations (Figure 2D) were associated with mitochondrial depolarization. Since high VK3 concentrations (e.g. > 35 μM) induced nuclear and cytoplasmic destruction of cells (necrosis), thus avoiding a clear-cut evaluation of apoptotic morphology (data not shown), 10 μM VK3 was selected for further experiments.
Recently, it has been shown that mM concentrations of ascorbate were cytotoxic to neuroblastoma cells mediated by H2O2. Figure 1D shows that VC was capable to generate either O2.- or H2O2 at the indicated concentrations. Moreover, VC was moderately or highly toxic to Jurkat and K562 cells, respectively at high concentrations. Of note, whilst 1 mM VC induced apoptotic/necrotic morphology in K562, 10 mM concentration induces apoptosis in Jurkat to a similar extend provoked by (10 μM) VK3. Interestingly, VC was innocuous for lymphocyte cells at the indicated concentrations.
A ratio 1000: 1 and 100: 1 VC: VK3 provoke apoptosis in Jurkat cells and K562 cells, respectively
Table 1 shows that a ratio 100:1 (VC: VK3) did not affect Jurkat cells, but this ratio (300 VC: 3VK3) induced (~30%) apoptosis in K562, according to AO/EB and DiOC6(3) staining techniques. A ratio 1000:1 resulted in an effective toxic effect in Jurkat cell line.
VK3 and VC alone or in combination induce apoptosis through of reactive oxygen species
CP55,940  and N-acetyl-cysteine (NAC) antioxidants dramatically reduced apoptosis to almost control values and importantly abrogated H2O2 when cells where treated with VK3, VC alone or VK3 in combination with VC (Table 2). A similar protective effect was observed when K562 cells were exposed to (20 μM) VK3, (0.5 mM) VC and VC: VK3 in a ratio 300:3 and antioxidants (data not shown).
VK3 and VC alone or in combination induce apoptosis in Jurkat and K562 cells associated with NF-κB, p53 and c-Jun transcription factors and caspase-3 activation
Table 3 shows that all the specific pharmacological inhibitors reduced almost completely VK3- and VC-induced apoptosis and mitochondrial damage effect compared to control values, but moderately reduced cell death and Δψm when cells were exposed in combination (~30-44% reduction). To confirm the participation of NF-κB, p53, c-Jun and caspase-3 in VK3, VC and VK3 plus VC-induced apoptosis, we performed immunocytochemical assessment. As illustrated in Figure 3 B, D, F, and H, Jurkat cells incubated with 10 μM VK3 clearly showed DAB+ nuclei staining of the active form of NF-κB (~36%), p53 (~38%), c-Jun (~40%) and CASP-3 (~40%) compared to untreated cells (1-2% DAB+ nuclei), where inactive transcription factors and protease reside in the cytoplasm (Figure 3 A, C, E and G). In addition, immunocytochemical assessment of cells treated with VC alone showed DAB+ nuclei staining of NF-κB (~18%), p53 (~15%), c-Jun (~15%) and CASP-3 (~16%) (Figure 4 A, C, E and G, respectively) compared to untreated cells. Not surprisingly, treated cells with (10 μM) VK3 in combination with (10 mM) VC stained DAB+ for NF-κB (~38%, Figure 4B), p53 (~75%, Figure 4D), c-Jun (~48%, Figure 4F) and caspase-3 (~47%, Figure 4H) compared to untreated cells. Likewise, K562 cells treated with (500 μM) VC, (20 μM) VK3 and (300:3) VC/VK3 showed DAB+ nuclei staining for NF-κB, p53, c-Jun and CASP-3 to a similar extend as Jurkat cells (data not shown).
In the present study, we provide for the first time in vitro evidence supporting a causative role for oxidative stress in VK3-, and VC-induced apoptosis in Jurkat and K562 cells in a domino-like mechanism involving O2.-/H2O2, mitochondrial depolarization, transcription factor activation such as NF-κ, p53, and c-Jun converging in caspase-3 activation and apoptotic morphology. Most importantly, it is shown that high concentration of VC (e.g. 10 mM) alone or in combination with VK3 (e.g. 10 μM) in a ratio 1000:1 and 100:1 induced apoptosis in Jurkat and K562 cells, respectively by a comparable mechanism to VK3 (e.g. 10 μM) and VC (e.g. 10 mM) alone. Moreover, by using antioxidant compounds, we demonstrated that O2.-/H2O2 production are essential in VK3-and VC-induced cytotoxicity. This notion was further reinforced by the fact that the antioxidant CP55,940 and NAC completely protect leukemia cells against VK3- and VC-superoxide radicals and H2O2 toxicity. Most importantly, lymphocytes were more resistant to cell death induced either by VC or VK3 treatment alone than leukemia cells. We speculate that differences in cell cycle (i.e., lymphocytes are in Go cell cycle and cancer cells are constantly dividing cells), differences in glutathione content and/or differences in gene expression of antioxidant proteins (e.g., catalase, thioredoxin, superoxide dismutase, glutathione peroxidase) may explain resistance and/or vulnerability in lymphocyte and leukemia cells against VK3 and VC exposure. Taken together our results suggest that different compounds with varied chemical properties might present a similar oxidative stress mechanism of action to erode leukemia cells.
We confirm that VK3  and VC at high concentrations [13, 14, 26] generate O2.- and H2O2. Moreover, by using antioxidant compounds, it is shown that both reactive oxygen species are related to apoptotic morphology. Our result comply with the notion that H2O2, as a by-product of O2.- dismutation, provokes apoptosis in Jurkat and K562 cells . How H2O2 might be involved in cell death process? Takada and co-workers  have demonstrated that H2O2 induces NF-κB activation in Jurkat cells through the spleen tyrosine kinase (Syk). Alternatively, H2O2 may activate NF-κB through phosphorylation IκBα kinase (IKKα) and IKKβ ). In accordance with these observations, we found p65-DAB+ nuclei by immunohistochemistry technique in both cell lines treated with either VK3 or VC, as manifestation of p65 activation and translocation to the nuclei, but almost undetectable in untreated cells. Moreover, pharmacological inhibition of NF-κB with PDTC inhibited to almost control value the apoptotic morphology. Taken together these data suggest that VK3 and VC induce activation and translocation of the NF-κB (p65) probably via H2O2-induced mechanisms. Our results are in agreement with Jones et al. . However, our results differ from Han et al.  who showed VC toxicity in HL-60 cells through down-regulation of NF-κB activity. Although the nature of this discrepancy is not known, one possible explanation is that HL-60 cells constitutively express NF-κB (also called "NF-κB positive" cancer cells), which confers cell survival . We conclude that depending on the inducible or constitutive expression NF-κB profile in cells, NF-κB will be an important factor to determine the appropriate therapeutic strategy against lymphoblastic/myelogenous leukemia. Consequently, NF-κB may constitute an important therapeutic target . In accordance with other scientific reports and our present data suggest that activation of NF-κB is linked to cell death signaling in Jurkat and K562 cells . Indeed, NF-κB transcribes pro-apoptotic genes such as p53. Immunohistochemical detection of p53 may indicate that p53 can be directly up-regulated by NF-κB. Moreover, pharmacological inhibition of p53 by PFT completely abolishes VK3 and VC-evoked apoptosis. In contrast to Karczewski et al. , our data comply with the notion that p53 is involved in the mechanism of VK3 and VC toxicity in Jurkat and K562 cells . It is noteworthy to mention that p53 transcribes pro-apoptotic genes such as PUMA, Noxa, Bim, Bid, Bax, which are able to permeabilize mitochondria, thus promoting the release of the apoptogenic cytochrome c, which elicits caspase-3 protease activation, leading to nuclear chromatin fragmentation, typical of apoptotic morphology. In fact, caspase-3 NSCI inhibitor protected cells from those noxious stimuli. In contrast to Verrax et al. , our data clearly showed that VC, VK3 or VC/VK3 induced toxicity in Jurkat and K562 cells by caspase-3 dependent form of cell death.
According to immunohistochemical staining and pharmacological blockade, we found that VK3 and VC activate c-Jun. How, then, these concurrent signaling pathways are activated either by VK3, VC or H2O2? As mentioned above, H2O2 can directly activate NF-κB through Syk or indirectly by activation of the multisubunit IKKα/β by Syk or MEKK1/MAPKK kinase. Therefore, one possibility is that once MEKK1 is activated, it may serve as a cross talk molecule between the JNK and NF-κB pathway . Taken together our findings and this information, it is reasonable to assume that NF-κB and JNK/c-Jun are accomplices with each other during VK3/VC-induced apoptosis in leukemia cells. Furthermore, JNK interacts with p53 in response to stress . We conclude that induction of NF-κB, JNK/c-Jun, and p53 by VK3 and VC might be particularly suitable for the treatment of leukemia [31, 36].
During the last decade, VC and VK3 administered in a ratio 100:1 respectively, exhibit synergistic anti-tumor activity by a cell death process denominated autoschizis. This cell death is a type of necrosis characterized by exaggerated membrane damage and progressive loss of cytoplasm through a series of self-excisions . Because cell death is a pure morphological phenomenon , we used acridine orange/ethidium bromide (AO/EB) staining as one of the most reliable and unbiased method to identify live, (early and late) apoptotic and necrotic cell  compared to other standard methods . Therefore, we first consistently found that (10 μM) VK3 and (10 mM) VC induced (early and late) apoptosis judged against N,N,N′,N′-tetrakis-(2-Pyridylmethyl)ethylenediamine (5 μM, TPEN) reagent, which induces 100% nuclei apoptotic morphology in a caspase-3 and p53-dependent fashion in Jurkat cell line (control, data not shown). We found a ratio 100:1 VC: VK3 induced no cell death and mitochondrial damage in Jurkat cells. However, a significant percentage of (late) apoptotic morphology and depolarized mitochondria in cells were provoked by a ratio 1000:1 (VC: VK3) compared to cells treated with VC and VK3 alone. In agreement with others data, it is found that a ratio 100:1 VC: VK3 induced cell death and mitochondrial damage in K562. Strikingly, Jurkat and K562 cells showed classical apoptosis and necrosis  rather than autoschizis morphology . Furthermore, it was found that (1000:1; 100:1) VC/VK3 activates NF-κB, p53, c-Jun and caspase-3, typical of apoptosis. In agreement with Sakagami et al  and Ogawa et al. , altogether our data suggest that VK3 and VC induce apoptosis in leukemia cells by oxidative stress . In contrast to other reports [15, 42–44], our data suggest that autoschizis might not be operative, at least under the present experimental conditions, in Jurkat and K562 cells. Taken together these results imply that VC- and VK3-induced autoschizis is a cell-specific rather than universal cell death process. Altogether our data suggest that a (1000:1; 100:1) VC: VK3 dose should be an intravenously therapeutic dose in the treatment of lymphoblastic and myelogenous leukemia.
We provide evidence that VK3 and VC alone or in combination induces apoptosis in leukemia cells by a sequential cascade of molecular events involving the production of ROS, simultaneous activation of NF-κB/p53/c-Jun transcription factors, mitochondrial depolarization and caspase-3 activation pathway. These data confirm our hypothesis that VK3 and VC kill leukemia cells by oxidative stress mechanism. Most importantly, VK3 and VC are harmless to lymphocytes, at least under the present in vitro conditions. Taken together our results support the notion that oxidative stress may play an important role in the killing of leukemia cells.
Reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA) if not otherwise specified and were of analytical grade or better. 3,3'-dihexyloxacarbocyanine iodide (DiOc6(3), cat # D-273) was obtained from Invitrogen Molecular Probes (Eugene, OR, USA). Ammonium pyrrolidinedithiocarbamate (PDTC, cat. # 548000) and 1,9-pyrazoloanthrone (SP600125, cat # 420119) were acquired from Calbiochem (San Diego, CA, USA).
Isolation of lymphocytes
Peripheral blood lymphocytes were obtained from healthy adult (30-40 years old) males' venous blood by gradient centrifugation (lymphocyte separation medium, density: 1.007 G/M; Bio-Whittaker Inc., Walkersville, MD, USA) and cultured as described elsewhere .
Cancer cell culture
Jurkat clone E6-1 (ATCC® Catalog No. TIB-152™) and K562 (ATCC® Catalog No. CCL-243™) were cultured according to supplier's indications. Cells at 1 × 106 cells/mL (passage 5-10) were exposed to Vitamin K3 (VK3) and/or Vitamin C (VC) and other products of interest.
Experiments with leukemia cell line and lymphocyte cells
Morphological assessment of cell death by fluorescence microscopy using acridine orange/ethidium bromide (AO/EB) double staining
The cell suspension (1 mL, final volume) was exposed to increasing vitamin K3 (1, 5, 10, 20, 35, 50 μM), vitamin C (ascorbic acid at pH 7; 0.1, 0.5, 1, 5, 10, 20 mM) or 10 mM VC: 10 μM VK3 concentrations freshly prepared in RPMI-1640 medium in the absence or presence of different products of interest for 24 h at 37 °C. The cells were then used for fluorescent microscopy analysis as detailed elsewhere .
Evaluation of intracellular reactive oxygen species
Assessment of superoxide anion radical generation
Superoxide anion radicals were evaluated as described elsewhere . Formazan was quantified under a light microscope (Zeiss Axiostart 50).
Assessment of Hydrogen peroxide
H2O2 was evaluated as described elsewhere , except that 2',7'-dichlorofluorescein diacetate (DCFH2-DA) was used instead of dihydrorhodamine 123 (DHR-123). Green fluorescent cells (reflecting H2O2 production) were quantified under a fluorescence microscope.
Qualitative analysis of mitochondrial membrane potential (Δψm)
The cancer cell lines were treated as described above and incubated with cationic lipophilic DiOC6(3) (1 μM, final concentration) to evaluate Δψm as detailed elsewhere . Green fluorescent cells (reflecting high-polarized and low-polarized mitochondria) were quantified under a fluorescence microscope.
Immunocytochemistry detection of NF-κB, p53 and c-Jun transcription factor and caspase-3 protein
The Santa Cruz Biotechnology supplier protocol (goat ABC staining System: cat # sc-2023) was followed for the immunocytochemistry using primary goat polyclonal antibodies NF-κB p65 (C-20)-G (cat#sc-372-G), p53 (FL-393) (cat #sc-6243-G), p-(Ser 73)-c-Jun (cat #sc-7981) and caspase-3 (cat #sc-22171). Immunocytochemistry procedure was performed as detailed elsewhere . DAB+ cells were quantified under a light microscope.
The light microscopy and fluorescent photomicrographs shown in figures and supplemental ones were taken using a Zeiss (Axiostart 50) microscope equipped with a Canon PowerShot G5 digital camera.
The aforementioned parameters were quantified by counting a minimum of 500 total cells blind to experimental setting and viewer. The experiments were performed in 3 independent settings. Data are means ± S.D. of three independent experiments. One-way ANOVA analyses with Bonferroni or Games-Howell post-hoc comparison were calculated with SPSS 18 software. A p-value of < 0.05 and < 0.001 was considered significant.
- ammonium pyrrolidinedithiocarbamate:
- anion superoxide radical:
c-Jun N-terminal kinase
7'-dichlorofluorescein diacetate: DCFH2-DA
3' dihexyloxacarbocyanine iodide: DiOc6(3)
- hydrogen peroxide:
- mitochondrial transmembrane potential:
nuclear factor-kappa B
reactive oxygen species.
Chen W, Wang E, Lu Y, Gaal KK, Huang Q: Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review. Am J Clin Pathol. 2010, 133 (1): 75-82. 10.1309/AJCPYWC6AQC7BAVJ.
Gregory CD, Pound JD: Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J Pathol. 2011, 223 (2): 177-194.
Baran I, Ganea C, Scordino A, Musumeci F, Barresi V, Tudisco S, Privitera S, Grasso R, Condorelli DF, Ursu I, Baran V, Katona E, Mocanu MM, Gulino M, Ungureanu R, Surcel M, Ursaciuc C: Effects of menadione, hydrogen peroxide, and quercetin on apoptosis and delayed luminescence of human leukemia Jurkat T-cells. Cell Biochem Biophys. 2010, 58 (3): 169-179. 10.1007/s12013-010-9104-1.
Lee W-J: The prospects of vitamin C in cancer therapy. Immune network. 2009, 9: 147-152. 10.4110/in.2009.9.5.147.
Lamson DW, Gu YH, Plaza SM, Brignall MS, Brinton CA, Sadlon AE: The vitamin C: vitamin K3 system - enhancers and inhibitors of the anticancer effect. Altern Med Rev. 2010, 15 (4): 345-351.
Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16 (1): 3-11. 10.1038/cdd.2008.150.
Di Monte D, Bellomo G, Thor H, Nicotera P, Orrenius S: Menadione-induced cytotoxicity is associated with protein thiol oxidation and alteration in intracellular Ca2+ homeostasis. Arch Biochem Biophys. 1984, 235 (2): 343-350. 10.1016/0003-9861(84)90207-8.
Ma X, Du J, Nakashima I, Nagase F: Menadione biphasically controls JNK-linked cell death in leukemia Jurkat T cells. Antioxid Redox Signal. 2002, 4 (3): 371-378. 10.1089/15230860260196173.
Caricchio R, Kovalenko D, Kaufmann WK, Cohen PL: Apoptosis provoked by the oxidative stress inducer menadione (Vitamin K(3)) is mediated by the Fas/Fas ligand system. Clin Immunol. 1999, 93: 65-74. 10.1006/clim.1999.4757.
Laux I, Nel A: Evidence that oxidative stress-induced apoptosis by menadione involves Fas-dependent and Fas-independent pathways. Clin Immunol. 2001, 101 (3): 335-344. 10.1006/clim.2001.5129.
Jones BE, Lo CR, Liu H, Pradhan Z, Garcia L, Srinivasan A, Valentino KL, Czaja MJ: Role of caspases and NF-kappaB signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol. 2000, 278 (5): G693-G699.
Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, Chen S, Corpe C, Dutta A, Dutta SK, Levine M: Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003, 22 (1): 18-35.
Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M: Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA. 2005, 102 (38): 13604-13609. 10.1073/pnas.0506390102.
Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M: Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA. 2008, 105 (32): 11105-11109. 10.1073/pnas.0804226105.
Verrax J, Delvaux M, Beghein N, Taper H, Gallez B, Buc Calderon P: Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study. Free Radic Res. 2005, 39 (6): 649-657.
Radhakrishnan SK, Kamalakaran S: Pro-apoptotic role of NF-kappaB: implications for cancer therapy. Biochim Biophy Acta. 2006, 1766: 53-62.
Chipuk JE, Green DR: Dissecting p53-dependent apoptosis. Cell Death Differ. 2006, 13: 994-1002. 10.1038/sj.cdd.4401908.
Shen H-M, Liu Z-G: JNK signalling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Rad Biol Med. 2006, 40: 928-939. 10.1016/j.freeradbiomed.2005.10.056.
Fan TJ, Han LH, Cong RS, Liang J: Caspase family proteases and apoptosis. Acta Biochim Biophys. 2005, 37: 719-727.
Verrax J, Taper H, Buc Calderon P: Targeting cancer cells by an oxidant-based therapy. Curr Mol Pharmacol. 2008, 1 (1): 80-92.
Cabanillas F: Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?. P R Health Sci J. 2010, 29 (3): 215-217.
Leite M, Quinta-Costa M, Leite PS, Guimaraes JE: Critical evaluation of techniques to detect and measure cell death- study in a model of UV radiation of the leukaemic cell line HL60. Anal Cell Pathol. 1999, 19: 139-151.
Deubzer B, Mayer F, Kuçi Z, Niewisch M, Merkel G, Handgretinger R, Bruchelt G: H(2)O(2)-mediated cytotoxicity of pharmacologic ascorbate concentrations to neuroblastoma cells: potential role of lactate and ferritin. Cell Physiol Biochem. 2010, 25 (6): 767-774. 10.1159/000315098.
Velez-Pardo C, Jimenez-Del-Rio M, Lores-Arnaiz S, Bustamante J: Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure. Neurochem Res. 2010, 35 (9): 1323-1332. 10.1007/s11064-010-0188-1.
Lin C, Kang J, Zheng R: Vitamin K3 triggers human leukemia cell death through hydrogen peroxide generation and histone hyperacetylation. Pharmazie. 2005, 60 (10): 765-771.
Park S, Han SS, Park CH, Hahm ER, Lee SJ, Park HK, Lee SH, Kim WS, Jung CW, Park K, Riordan HD, Kimler BF, Kim K, Lee JH: L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms. Int J Biochem Cell Biol. 2004, 36 (11): 2180-2195. 10.1016/j.biocel.2004.04.005.
Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, Aggarwal BB: Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem. 2003, 278 (26): 24233-24241. 10.1074/jbc.M212389200.
Kamata H, Manabe T, Oka S, Kamata K, Hirata H: Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett. 2002, 519 (1-3): 231-237. 10.1016/S0014-5793(02)02712-6.
Han SS, Kim K, Hahm ER, Lee SJ, Surh YJ, Park HK, Kim WS, Jung CW, Lee MH, Park K, Yang JH, Yoon SS, Riordan NH, Riordan HD, Kimler BF, Park CH, Lee JH, Park S: L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J Cell Biochem. 2004, 93 (2): 257-270. 10.1002/jcb.20116.
Jenkins C, Hewamana S, Gilkes A, Neelakantan S, Crooks P, Mills K, Pepper C, Burnett A: Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia. Br J Haematol. 2008, 143 (5): 661-671. 10.1111/j.1365-2141.2008.07392.x.
Lopez-Guerra M, Colomer D: NF-kappaB as a therapeutic target in chronic lymphocytic leukemia. Exp Opin Ther Targets. 2010, 14: 275-288. 10.1517/14728221003598930.
Karczewski JM, Vet JA, Hessels D, Noordhoek J: p53-independent apoptosis induced by menadione in the human colon carcinoma cell line Caco-2. Ann N Y Acad Sci. 2000, 915: 275-278.
Harakeh S, Diab-Assaf M, Khalife JC, Abu-el-Ardat KA, Baydoun E, Niedzwiecki A, El-Sabban ME, Rath M: Ascorbic acid induces apoptosis in adult T-cell leukemia. Anticancer Res. 2007, 27 (1A): 289-298.
Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K: Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ. 2006, 13 (5): 730-777. 10.1038/sj.cdd.4401830.
Buschmann T, Potapova O, Bar-Shira A, Ivanov VN, Fuchs SY, Henderson S, Fried VA, Minamoto T, Alarcon-Vargas D, Pincus MR, Gaarde WA, Holbrook NJ, Shiloh Y, Ronai Z: Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol Cell Biol. 2001, 21 (8): 2743-2754. 10.1128/MCB.21.8.2743-2754.2001.
Saha MN, Micallef J, Qiu L, Chang H: Pharmacological activation of the p53 pathway in haematological malignancies. J Clin Patol. 2010, 63: 204-209. 10.1136/jcp.2009.070961.
Jamison JM, Gilloteaux J, Taper HS, Calderon PB, Summers JL: Autoschizis: a novel cell death. Biochem Pharmacol. 2002, 63 (10): 1773-1783. 10.1016/S0006-2952(02)00904-8.
Mattes MJ: Apoptosis assays with lymphoma cell lines: problems and pitfalls. Br J Cancer. 2007, 96 (6): 928-936. 10.1038/sj.bjc.6603663.
Sakagami H, Satoh K, Hakeda Y, Kumegawa M: Apoptosis-inducing activity of vitamin C and vitamin K. Cell Mol Biol (Noisy-le-grand). 2000, 46 (1): 129-143.
Ogawa M, Nakai S, Deguchi A, Nonomura T, Masaki T, Uchida N, Yoshiji H, Kuriyama S: Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Int J Oncol. 2007, 31 (2): 323-331.
Wang J, Yi J: Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol & Therapy. 2008, 7: 1875-1884. 10.4161/cbt.7.12.7067.
Gilloteaux J, Jamison JM, Lorimer HE, Jarjoura D, Taper HS, Calderon PB, Neal DR, Summers JL: Autoschizis: a new form of cell death for human ovarian carcinoma cells following ascorbate: menadione treatment. Nuclear and DNA degradation. Tissue Cell. 2004, 36 (3): 197-209. 10.1016/j.tice.2004.01.006.
Gilloteaux J, Jamison JM, Neal DR, Summers JL: Cell death by autoschizis in TRAMP prostate carcinoma cells as a result of treatment by ascorbate: menadione combination. Ultrastruct Pathol. 2005, 29 (3-4): 221-235. 10.1080/01913120590951239.
Gilloteaux J, Jamison JM, Neal DR, Loukas M, Doberzstyn T, Summers JL: Cell damage and death by autoschizis in human bladder (RT4) carcinoma cells resulting from treatment with ascorbate and menadione. Ultrastruct Pathol. 2010, 34 (3): 140-160. 10.3109/01913121003662304.
Avila-Gomez IC, Velez-Pardo C, Jimenez-Del-Rio M: Effects of insulin-like growth factor-1 on rotenone-induced apoptosis in lymphocyte cells. Basic & Clinical Pharmacology & Toxicology. 2010, 106: 53-61.
Melinn M, McLaughlin H: Nitroblue tetrazolium reduction in lymphocytes. J Leukoc Biol. 1987, 41: 325-329.
This work was supported by Colciencias grant # 1115-408-20525 to CV-P and MJ-Del-Rio. ARB-P is at the Master Program in Biomedical Science from the UdeA. ARB-P was supported by "Programa Jóvenes Investigadores e Innovadores "Virginia Gutiérrez de Pineda" Colciencias grant #JIC-018-2010, and "Programa de Sostenibilidad-UdeA 2010-2011".
The authors declare that they have no competing interests.
ARBP performed experiments and analyzed data; MJDR. and CVP. conceived and designed the study, analyzed and interpreted data, wrote the manuscript and all authors gave final approval of submitted manuscript.